Kittai, Adam S.

Immune Checkpoint Inhibitors in Organ Transplant Patients

Kittai, A. S., Oldham, H., Cetnar, J., & Taylor, M. (2017) · Journal of Immunotherapy

Cancer Immunotherapy and BiomarkersTransplantation: Methods and Outcomes

Cited by 151

Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial.

Falchi, L., Nijland, M., Huang, H., Linton, K. M., Seymour, J. F., Tao, R., Kwiatek, M., Costa, A., Vassilakopoulos, T. P., Greil, R., et al. (2026) · The Lancet

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research

Cited by 41

Concordance between bone marrow and blood measurable residual disease after first-line novel agent treatment for chronic lymphocytic leukemia: a systematic review and meta-analysis

Fiorica, G., Wehmeyer, G., Yee, C. I., Segovia, D., Rios-Olais, F. A., Hilal, T., & Kittai, A. S. (2026) · Leukemia

Chronic Lymphocytic Leukemia ResearchAcute Lymphoblastic Leukemia research

Cited by 0